Safety Surveillance During the Introduction of Novel Oral Poliovirus Vaccine Type 2 (nOPV2) in the Central African Republic: Findings from Passive AEFI and Active AESI Surveillance
Georges Rodrigue Kouatcho, Salfo Ouédraogo, G Tekpa, Marie Thérèse Line Mboliyou Tondogba et autres